Only 57% of people with diabetes have well-controlled blood glucose levels — defined by the American Diabetes Association as a three-month target blood glucose level (hemoglobin A1c) of less than 7% or defined by the American Association of Clinical Endocrinologists as less than 6.5%. For some people with diabetes, help may already be here in the form of the daily or weekly dosed glucagon-like-peptide-1 receptor agonists exenatide (Byetta, Bydureon), liraglutide (Victoza), dulaglutide (Trulicity), albiglutide (Tanzeum) and the amylin analog pramlintide acetate (Symlin). Many nurses and dietitians who work with patients with diabetes will have the responsibility of educating and monitoring patients who are using these important new treatments.
The goal of this program is to enhance nurses’ and dietitians’ ability to care for patients taking new injectable classifications of medications for diabetes. After studying the information presented here, you will be able to:
- Describe the roles of amylin and the human incretin hormone glucagon-like-peptide-1 in regulating blood glucose levels
- Explain three benefits of GLP-1 receptor agonists and amylin analog injection therapy
- Discuss three nursing interventions to help patients adjust to and properly use GLP-1 receptor agonists or amylin analog therapy
This course is intended for multiple professions, including dietitians, health educators, and nurses.
Health educators: Take this version of the course to ensure you receive appropriate credit.
For the version accredited or approved for another profession, go to your specific profession at www.continuingeducation.com
. If you have a CE Direct login ID and password (generally provided by your employer), please log in as you normally would at lms.nurse.com
and search for this topic title.
Sponsored by OnCourse Learning, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 1.0 total Category I continuing education contact hours.
Provider ID: CA0084 (98709) for 01/01/2012 to 12/31/2015, 114941 for 01/01/2016 to 12/31/2019.
Course Originally Released on:
Date of Most Recent Review:
Course Termination/Update Date:
Unless stated above, the planners and authors of this course have declared no relevant conflicts of interest that relate to this educational activity. OnCourse Learning guarantees this educational activity is free from bias.
Please see CE Course Instructions to learn how to earn CE credit for this module.